A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2011
12/29/2011	US20110319368 Once daily formulations of tetracyclines
12/29/2011	US20110319367 Phenazopyridine Compounds
12/29/2011	US20110319366 Plasma Carboxypeptidase B Inhibitors
12/29/2011	US20110319365 Complexes of 4-hydroperoxy ifosfamide as anti-tumor agents
12/29/2011	US20110319364 Foaming alcohol compositions with selected dimethicone surfactants
12/29/2011	US20110319363 Novel phosphonic acid compounds as inhibitors of serine proteases
12/29/2011	US20110319362 Stat3 ligands and therapeutic uses thereof
12/29/2011	US20110319361 Boron-containing small molecules
12/29/2011	US20110319360 Method of including apoptosis/Cell death in leukemia cell using a purine nucleoside analogue
12/29/2011	US20110319359 Indanyl compounds
12/29/2011	US20110319358 Glucosamine and method of making glucosamine from microbial biomass
12/29/2011	US20110319357 Hyaluronic Acid Derivatives
12/29/2011	US20110319356 Methods Of Treating Optic Disorders
12/29/2011	US20110319355 Methods for treating non-small cell lung cancer using 5-azacytidine
12/29/2011	US20110319354 Combination Cancer Therapy with an AKT Inhibitor and Other Anticancer Agents
12/29/2011	US20110319353 Treatment for spinal muscular atrophy
12/29/2011	US20110319352 Compounds That Bind Oxysterol Binding Proteins, and Methods of Use Thereof
12/29/2011	US20110319351 Treating cancer with cardiac glycosides
12/29/2011	US20110319350 Glycoside compounds and pharmaceutical compositions thereof
12/29/2011	US20110319349 Methods for Reducing Platelet Activation and for the Treatment of Thrombotic Events
12/29/2011	US20110319348 Brassinosteroids in treating prostatic hyperplasia and androgenic alopecia
12/29/2011	US20110319333 Method and compositions for the treatment and detection of endothelin-1 related kidney diseases
12/29/2011	US20110319326 Derivatives of benzothiazines, preparation thereof and application thereof as drugs
12/29/2011	US20110319325 Multi-component pharmaceuticals for treating diabetes
12/29/2011	US20110319317 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirt1
12/29/2011	US20110319267 Aromatic carboxylic acid derivatives for treatment and prophylaxis of gastrointestinal diseases including colon cancers
12/29/2011	US20110318834 Multiple-tumor aberrant growth genes
12/29/2011	US20110318832 Human Telomerase Catalytic Subunit
12/29/2011	US20110318461 Peracid and 2-hydroxy organic acid compositions and methods for treating produce
12/29/2011	US20110318439 Plant extracts from acronychia species and their use
12/29/2011	US20110318434 Acne Vulgaris Treatment Regimen
12/29/2011	US20110318432 Compositions for the treatment of gastro-esofageal reflux disease (gerd)
12/29/2011	US20110318430 Tumor therapy with antitumor agents in combination with sindbis virus-based vectors
12/29/2011	US20110318425 TREATMENT OF INTERSTITIAL CYSTITIS USING (6aR, 10aR)- DELTA-8-TETRAHDRAOCANNABINOL-11-OIC ACIDS
12/29/2011	US20110318424 METHODS FOR PROLONGING VIABILITY OF CONE CELLS USING MODULATORS OF THE MAMMALIAN TARGET OF RAPAMYCINE (mTOR)
12/29/2011	US20110318420 Fulvestrant nanosphere/microsphere and preparative method and use thereof
12/29/2011	US20110318418 Compositions of 5-ethyl-2--pyrimidine
12/29/2011	US20110318417 Highly pure cinacalcet or a pharmaceutically acceptable salt thereof
12/29/2011	US20110318416 Bioresorbable polymer matrices and methods of making and using the same
12/29/2011	US20110318413 Extended release formulations containing darifenacin or pharmaceutically acceptable salts thereof
12/29/2011	US20110318412 Low dose doxepin formulations, including buccal, sublingual and fastmelt formulations, and uses of the same to treat insomnia
12/29/2011	US20110318411 Multi-layered orally disintegrating tablet and the manufacture thereof
12/29/2011	US20110318406 Lecithin carrier vesicles and methods of making the same
12/29/2011	US20110318405 Chemical Combination and Method for Increasing Delivery of Coenzyme Q10
12/29/2011	US20110318396 Dermatological/cosmetic compositions comprising a retinoid and benzoyl peroxide
12/29/2011	US20110318394 Multi-linked star-shaped polymers and synthetic methods therfor
12/29/2011	US20110318393 Substituted Pyrazole Compounds
12/29/2011	US20110318392 Drug coating providing high drug loading and methods for providing the same
12/29/2011	US20110318391 Bioactive Dose Having Containing a Material for Modulating pH of a Bodily Fluid to Help or Hinder Absorption of a Bioactive
12/29/2011	US20110318390 Bioactive Dose Having a Rapid Release Coating or Rapid Release Layer Containing a Material for Modulating pH of a Bodily Fluid to Help or Hinder Absorption of a Bioactive
12/29/2011	US20110318388 S1P Receptors Modulators and Their Use Thereof
12/29/2011	US20110318382 Immunomodulatory agents and methods of use
12/29/2011	US20110318367 Novel targets for treatment of hypercholesterolemia
12/29/2011	US20110318365 Methods for treatment of degenerative disease associated with apoptosis
12/29/2011	US20110318363 Specific TT virus sequences and chimeric TT virus host cell DNA molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity
12/29/2011	US20110318362 Novel card proteins involved in cell death regulation
12/29/2011	US20110318361 Anticancer Drug Comprising Inhibitor of Tmprss4
12/29/2011	US20110318359 Method for reducing blood pressure using inhibitors of plasma kallikrein
12/29/2011	US20110318355 Mutant proteins of the f protein of piv-5 and piv-2
12/29/2011	US20110318351 Novel methods of cancer diagnosis and therapy targeted against a cancer stem line
12/29/2011	US20110318346 Alpha B-crystallin as a therapy for Ischemia or inflammation
12/29/2011	US20110318345 Nasal delivery
12/29/2011	US20110318338 Targeting pax2 for the treatment of breast cancer
12/29/2011	US20110318336 Identification and Treatment of Aggressive Lung Cancer Tumors
12/29/2011	US20110318335 Methods and products for treating proliferative diseases
12/29/2011	US20110318334 Taxane analogs for the treatment of brain cancer
12/29/2011	US20110318329 Method of treatment or prophylaxis
12/29/2011	US20110318321 Controlled release pharmaceutical or food formulation and process for its preparation
12/29/2011	US20110318320 Nutritional supplements for women desiring to become pregnant, and pregnant and nursing women
12/29/2011	US20110318317 Chinese hamster apoptosis-related genes
12/29/2011	US20110318316 Chinese hamster apoptosis-related genes
12/29/2011	US20110318308 Lipocalin-type prostaglandin d2 synthase as a biomarker for lung cancer progression and prognosis
12/29/2011	US20110318305 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
12/29/2011	US20110318298 Viral infection therapeutic drug containing polyalkyleneimine
12/29/2011	US20110318287 Anti-fungal nail polish
12/29/2011	US20110318280 Polymeric anti-microbial agents
12/29/2011	US20110318275 Multifunctional contrast agent using biocompatible polymer and preparation method
12/29/2011	US20110318271 Arginase Inhibitors for the Treatment of Depression
12/29/2011	US20110318270 Drug identification protocol for type 2 diabetes based on gene expression signatures
12/29/2011	US20110318267 Ph-responsive nanostructures
12/29/2011	US20110318265 Coupled identification and treatment of cancer
12/29/2011	US20110318264 Methods and compositions for diagnosis and treatment of cancer
12/29/2011	US20110315583 Intravascular indwelling catheter lock solution containing weak acid and container containing the same
12/29/2011	DE102010030538A1 6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln 6,7-dihydro-5H-benzo [7] annulene derivatives, processes for their preparation, pharmaceutical compositions containing them, and their use for the preparation of medicaments
12/29/2011	DE102010025173A1 Verwendung von Dibenzofuranonderivaten zur Inhibierung von Kinasen Use of Dibenzofuranonderivaten for inhibiting kinases
12/29/2011	CA2836445A1 Methods of treating optic disorders
12/29/2011	CA2806162A1 Composition and method of treating lipid encapsulated virus infections
12/29/2011	CA2803923A1 Methods of using sterculic acid
12/29/2011	CA2803920A1 Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity
12/29/2011	CA2803913A1 Tumor growth controlling method targeting galactosylceramide expression factor-1
12/29/2011	CA2803890A1 Antimicrobial agents
12/29/2011	CA2803882A1 Treatment of sodium channel, voltage-gated, alpha subunit (scna) related diseases by inhibition of natural antisense transcript to scna
12/29/2011	CA2803874A1 Intravaginal devices comprising anticholinergic agents, and methods of making thereof
12/29/2011	CA2803872A1 Methods of treating conditions associated with overactive bladder
12/29/2011	CA2803802A1 Pyrrolo- pyrazine derivatives useful as inhibitors of atr kinase
12/29/2011	CA2803697A1 Beta carboline derivatives useful in the treatment of proliferative disorders
12/29/2011	CA2803690A1 6,7-dihydro-5h-benzo[7]annulene derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and the use thereof for production of medicaments
12/29/2011	CA2803688A1 Use of stimulators and activators of soluble guanylate cyclase for treating sickle-cell anemia and conserving blood substitutes
12/29/2011	CA2803673A1 Salts and polymorphs of dexrabeprazole
12/29/2011	CA2803559A1 Nilotinib salts and crystalline forms thereof

1 ... 1418 1419 1420 1421 1422 1423 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 ... 7860